FinnCap reaffirmed their corporate rating on shares of Omega Diagnostics Group Plc (LON:ODX) in a report released on Tuesday morning. The brokerage currently has a GBX 30 ($0.39) target price on the stock.

Omega Diagnostics Group Plc (ODX) opened at GBX 19.50 ($0.26) on Tuesday. Omega Diagnostics Group Plc has a 1-year low of GBX 16.60 ($0.22) and a 1-year high of GBX 28.01 ($0.37).

COPYRIGHT VIOLATION NOTICE: “Omega Diagnostics Group Plc’s (ODX) “Corporate” Rating Reiterated at FinnCap” was reported by Watch List News and is the sole property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The correct version of this story can be read at

Omega Diagnostics Group Plc Company Profile

Omega Diagnostics Group PLC is a medical diagnostics company. The Company’s segments are Allergy and Autoimmune; Food Intolerance; Infectious/Other, and Corporate. Its product categories include allergy, anemia, autoimmunity, fertility and growth hormones, food intolerance, infectious disease, inflammation, quality control, thyroid hormones and tumor markers.

Receive News & Ratings for Omega Diagnostics Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.